Help Rural HCT Recipients Overcome Barriers to Post-Treatment Care
For patients with hematologic malignancies and genetic immune disorders, HCT is a potentially curative treatment. However, because the therapy is so specialized, only select cancer centers with the appropriate expertise, resources, and experiences offer it.
September 10, 2013